T2 Biosystems (TTOO) T2SARS-CoV-2 Panel Proves Capable of Detecting the Brazil P.1 Variant of the SARS-CoV-2 Virus

Go back to T2 Biosystems (TTOO) T2SARS-CoV-2 Panel Proves Capable of Detecting the Brazil P.1 Variant of the SARS-CoV-2 Virus

T2 Biosystems T2SARS-CoV-2™ Panel Proves Capable of Detecting the Brazil P.1 Variant of the SARS-CoV-2 Virus

February 4, 2021 4:05 PM EST

Panel is capable of detecting 99.99% of all currently identified SARS-CoV-2 viruses based on sequence alignments and in silico analysis

LEXINGTON, Mass., Feb. 04, 2021 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ: TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced that its T2SARS-CoV-2 Panela molecular diagnostic test that detects SARS-CoV-2, the virus responsible for COVID-19 infectionsis capable of detecting the Brazil (P.1) variant of the SARS-CoV-2 virus, which was recently confirmed to be present in the United States.

We continue to actively monitor new variants... More